肝细胞癌（HCC）是一种高发性恶性肿瘤，其循环肿瘤细胞（CTCs）由于上皮-间质转化（EMT）和间质-上皮转化（MET）表现出显著的表型异质性和不同的基因表达谱。然而，现有检测方法缺乏同时定量多维生物标志物的能力，这限制了对肿瘤生物学特性和动态变化的全面理解。如何实现对肝癌CTCs的多维度分子特征进行精确且统一的定量分析，已成为当前研究的热点。

In that respect it follows a similar model to Merck's takeover of AmpTec, another CDMO that uses a PCR platform to make mRNA drugs, for an undisclosed sum last year. Outsourcing services are on of ...

The following is a summary of “Association of mRNA COVID-19 vaccination and reductions in Post-COVID Conditions following SARS-CoV-2 infection in a US prospective cohort of essential workers,” ...

(NASDAQ:MRNA) announced the initiation of INTerpath ... patients who did not achieve a pathological complete response (pCR) after receiving neoadjuvant Keytruda plus platinum-based chemotherapy.

That clinical severity is a function of Pmp22 mRNA expression is suggested by the ... position of primers used for quantitative real-time PCR and genotyping. Transcripts containing exon 1A ...

Gen-Probe is currently developing the APTIMA HPV Assay, targeting E6/E7 mRNA from 14 carcinogenic HPV genotypes. A prototype of this assay was evaluated recently in 536 women with histological ...

Final step before the full launch of breast cancer screening program, RevealiaSPARKS, NV / ACCESSWIRE / November 7, 2024 / Ludwig Enterprises, Inc. (OTC PINK:LUDG), a leading USA-based biotechnology c ...